SURPRISE Study Group
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Success of Tocilizumab in RA Patients With Remission Induction and Sustained Efficacy After Discontinuation (NCT01120366) | SURPRISE Study Group | 2009-10-01 |
Track SURPRISE Study Group automatically
Every clearance here is in the API, with alerts when new ones post.